Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee gives positive opinion to brodalumab for plaque psoriasis

May 23, 2017

Cariprazine granted positive opinion in Europe for the treatment of schizophrenia

May 23, 2017

Cardioxane receives positive CHMP opinion in Europe

May 22, 2017

Articular cartilage product granted positive opinion from CHMP for European approval

May 22, 2017

Chiesi's triple combination for the treatment of COPD receives positive opinion from EMA

May 22, 2017

EMA accepts for review MAA for adalimumab biosimilar, FKB-327

May 22, 2017

EMA committee backs approval of Zykadia for first-line use in ALK+ NSCLC

May 22, 2017

EMA validates application seeking expanded approval of Sprycel

May 22, 2017

CHMP recommends approval of Insulin lispro Sanofi

May 22, 2017

EMA committee hands down positive opinion on Veltassa for treatment of hyperkalemia

May 19, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...